Obsidian Therapeutics, Inc. (NASDAQ:OBX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Peter Barrett Other companies: Synlogic Inc (Chairman, Partner, Atlas Venture · Since at least Jun 9, 2022); Revvity, Inc. (Partner, Atlas Venture · Since at least May 6, 2022); Larimar Therapeutics, Inc. (Director · May 10, 2022 – May 10, 2022 · Past) | Director · Since at least Aug 3, 2026 |
| Heidi Hagen Other companies: Vericel Corporation (Director · Since at least Aug 23, 2013); Alaunos Therapeutics, Inc. (Director · Jun 13, 2019 – Sep 2, 2021 · Past) | Director · Since at least Aug 3, 2026 |
| Julie B Feder Other companies: Aura Biosciences, Inc. (Chief Financial Officer · Oct 28, 2021 – Oct 18, 2024 · Past); Verastem, Inc. (Chief Financial Officer · Jul 10, 2017 – Apr 6, 2018 · Past) | Chief Financial Officer · Since at least Aug 3, 2026 |
| Caroline Code Other companies: Galera Therapeutics, Inc. (VP Corporate Development & Investor Relations · Since at least Apr 14, 2026) | VP Corporate Development and Investor Relations · Since at least Aug 5, 2026 |
| Maria Fardis Other companies: CRISPR Therapeutics AG (Director · Since at least Jun 5, 2025) | Director · Since at least Aug 3, 2026 |
| Matthew Norkunas Other companies: Generation Bio Co (CHIEF FINANCIAL OFFICER · Jan 22, 2021 – Jan 10, 2025 · Past) | Director · Since at least Aug 3, 2026 |
| Robert Ross Other companies: Xilio Therapeutics, Inc. (Board Member · Since at least Jun 14, 2024) | Director · Since at least Aug 3, 2026 |
| Madan Jagasia | Chief Executive Officer, Director · Since at least Aug 3, 2026 |
| Nicole Hsu | VP, Regulatory Affairs · Since at least Nov 5, 2026 |
| Parameswaran Hari | Chief Medical Officer · Since at least Aug 3, 2026 |